PRTA FY 2025 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$549M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M-92.8% YoY

Gross Profit

$6M61.8% margin

Operating Income

-$185M-1905.8% margin

Net Income

-$244M-2520.6% margin

EPS (Diluted)

$-4.53

Cash Flow

Operating Cash Flow

-$164M

Free Cash Flow

-$164M

Stock-Based Comp.

$38M

Balance Sheet

Total Assets

$327M

Total Liabilities

$46M

Stockholders' Equity

$280M

Cash & Equivalents

$308M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$135M	-92.8%
Gross Profit	$6M	$135M	-95.6%
Operating Income	-$185M	-$155M	-19.4%
Net Income	-$244M	-$122M	-99.6%